Document is current
Any future updates will be listed below
-
Authors
Martin, Dominique E.
Cadar, Andreia N.
Panier, Hunter
Torrance, Blake L.
Kuchel, George A.
Bartley, Jenna M. https://orcid.org/0000-0003-0302-975X
- License Information
-
More Information
Article History
Received: 8 November 2022
Accepted: 24 April 2023
First Online: 2 May 2023
Declarations
:
: The study protocol was approved by the Institutional Review Board at the University of Connecticut Health Center and registered at ClinicalTrials.gov (NCT03996538). The off-label use of metformin was approved under FDA Investigational New Drug (IND) 18974. All study participants provided written informed consent to participate in the study.
: Not applicable.
: The authors declare no competing interests.
